⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7159046 | 0.75 | TSHR (0.32) | — | |
| SCHEMBL4817611 | 0.71 | — | — | |
| SCHEMBL1967660 | 0.71 | — | — | |
| SCHEMBL638379 | 0.71 | — | — | |
| SCHEMBL13079463 | 0.69 | — | — | |
| SCHEMBL28113371 | 0.69 | — | — | |
| SCHEMBL133093 | 0.69 | — | — | |
| SCHEMBL7266979 | 0.67 | — | — | |
| SCHEMBL8639116 | 0.67 | — | — | |
| SCHEMBL11700756 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110046059-A1 | PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS | ZELOS THERAPEUTICS, INC. (US) | 2011-02-24 | — | — | US | claimed |
| WO-2011011675-A1 | PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS | ZELOS THERAPEUTICS, INC. (US) | 2011-01-27 | — | — | WO | claimed |
| US-20110046059-A1 | PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS | ZELOS THERAPEUTICS, INC. (US) | 2011-02-24 | — | — | US | disclosed |
| WO-2011011675-A1 | PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS | ZELOS THERAPEUTICS, INC. (US) | 2011-01-27 | — | — | WO | disclosed |